Tenofovir Gel for the Prevention of Herpes Simplex Virus Type 2 Infection

Abstract

In this study in South Africa, pericoital application of tenofovir gel reduced HSV-2 acquisition in women. (Funded by the U.S. Agency for International Development and others; ClinicalTrials.gov number, NCT00441298.).